phenacyl bromide has been researched along with 2-bromo-4'-nitroacetophenone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arabaci, G; Beebe, KD; Fu, H; Pei, D; Porter, ME; Yi, T | 1 |
| Conde, S; Martínez, A; Moreno, FJ; Perez, C; Pérez, DI | 1 |
| Conde, S; Dans, PD; Gil, C; Luque, FJ; Martínez, A; Palomo, V; Pérez, C; Perez, DI | 1 |
| Hoda, N; Maqbool, M; Mobashir, M | 1 |
| Ábrányi-Balogh, P; Barreteau, H; Ferenczy, GG; Fonovič, UP; Gobec, S; Horváti, K; Hrast, M; Ilaš, J; Imre, T; Keserű, GM; Kos, J; Mitrović, A; Németh, K; Petri, L; Roper, DI; Scarpino, A; Szijj, P | 1 |
1 review(s) available for phenacyl bromide and 2-bromo-4'-nitroacetophenone
| Article | Year |
|---|---|
Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Diabetes Mellitus; Glycogen Synthase Kinase 3; Hippocampus; Humans; Hypoglycemic Agents; Inflammation; Molecular Targeted Therapy; Neoplasms; Protein Kinase Inhibitors | 2016 |
4 other study(ies) available for phenacyl bromide and 2-bromo-4'-nitroacetophenone
| Article | Year |
|---|---|
alpha-bromoacetophenone derivatives as neutral protein tyrosine phosphatase inhibitors: structure-Activity relationship.
Topics: Acetophenones; Binding Sites; Enzyme Inhibitors; Indicators and Reagents; Kinetics; Peptides; Protein Tyrosine Phosphatases; Structure-Activity Relationship | 2002 |
Thienyl and phenyl alpha-halomethyl ketones: new inhibitors of glycogen synthase kinase (GSK-3beta) from a library of compound searching.
Topics: Adenosine Triphosphate; Databases, Factual; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Ketones; Kinetics; Protein Binding; Structure-Activity Relationship | 2003 |
Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: clues for specific design of new compounds.
Topics: Adenosine Triphosphate; Animals; Binding Sites; Cattle; Central Nervous System Agents; Cerebellum; Drug Design; Glycogen Synthase Kinase 3; Humans; In Vitro Techniques; Ketones; Mice; Models, Molecular; Neurodegenerative Diseases; Neurons; Phosphorylation; Protein Binding; Rats; Receptors, Neurotransmitter; Stereoisomerism; Structure-Activity Relationship; tau Proteins | 2011 |
A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
Topics: Alkyl and Aryl Transferases; Cysteine; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Humans; Ligands; Molecular Structure; Structure-Activity Relationship | 2018 |